Real moms, real GLP-1 talk
The Tirzepatide Dosing Schedule, Read the Way a Mom Would
The Zepbound dose ladder from the FDA label, the missed-dose rule, the birth-control windows, and what compounded tirzepatide programs do differently.
On this page
The short answer
The Zepbound label starts everyone at 2.5 mg once a week for four weeks, then 5 mg, and allows increases of 2.5 mg at a time after at least four weeks on the current dose1. The maintenance dose for weight is 5 mg, 10 mg or 15 mg, and 15 mg is the ceiling. Whether you move up, stay put or step back is a decision for your prescriber, not a calendar.
Why I wrote the ladder down
The question I see most is some version of "what dose should I be on by now?" I can't answer that for anyone, and I would not trust anyone online who says they can. What I can do is lay out what the FDA label actually says, because a lot of the confusion starts with schedules passed around in screenshots that are not the label at all.
The ladder, as written
| Step | Weekly dose | Earliest move up | Label notes |
|---|---|---|---|
| Start | 2.5 mg | After 4 weeks | For starting only, not a maintenance dose |
| 2 | 5 mg | After at least 4 more weeks | A maintenance option |
| 3 | 7.5 mg | After at least 4 more weeks | A step on the way |
| 4 | 10 mg | After at least 4 more weeks | A maintenance option |
| 5 | 12.5 mg | After at least 4 more weeks | A step on the way |
| 6 | 15 mg | None | The maximum |
Source: Zepbound prescribing information, sections 2.1 and 2.21.
The words that matter are "at least." Four weeks is the minimum time on each step, not a deadline. The label says to consider how you are responding and how well you tolerate it when choosing a maintenance dose, and to consider a lower one if you can't tolerate the one you are on1. For sleep apnea, the maintenance dose is 10 mg or 15 mg.
Lilly says the schedule is the same whether you use the single-dose pen, the KwikPen or a vial2. The price is not the same at every step, though, and the Zepbound savings card rules show the cash price jumping from $299 to $449 as the dose climbs. I would price the dose I expect to stay on, not the first box.
What the trial doses showed
In SURMOUNT-1, adults without diabetes who stayed assigned to 5 mg, 10 mg or 15 mg for 72 weeks lost an average of 15.0%, 19.5% and 20.9% of their weight, against 3.1% on placebo3. The gap between 10 mg and 15 mg was smaller than the gap between 5 mg and 10 mg. That is part of why "highest dose" is not automatically the goal, and a plateau on a lower dose is a conversation rather than an automatic increase. Trial averages also say nothing about how one person will respond.
If you miss a dose
The label rule is simple: take the missed dose as soon as you can within four days (96 hours). If more than four days have passed, skip it and take the next one on your usual day1. You can also change your injection day, as long as there are at least three days between two doses. The practical side of getting back on track after a forgotten weekly shot is mostly about refills and reminders. If you have missed several weeks in a row, I would call before restarting at the old dose, because stomach side effects are dose-related.
The birth-control windows
Every dose increase restarts one clock. The label says tirzepatide can make birth-control pills less effective, and advises switching to a non-oral method or adding a barrier method for four weeks after starting and for four weeks after each increase1. On the full ladder that is six separate windows. The Zepbound birth-control guide has the details. I would mark each window on a dose-step calendar next to the dose changes themselves. Hormonal methods that are not taken by mouth are not expected to be affected.
What compounded programs do differently
Compounded tirzepatide is not FDA approved, so there is no compounded label to follow4. Programs often keep the brand ladder as a reference, but they differ in ways that matter. Some sell one flat price at every dose, like CoreAge Rx at an advertised $129 a month or Gala Health at $179 a month on a yearly plan. Others measure doses in syringe units from a multi-dose vial, where the concentration decides what each mark means. Some offer smaller "microdose" plans that were never tested in the trials behind the label. Each of those choices changes what a "dose" means on that program.
The FDA says it has received reports of dosing errors when people measured compounded doses themselves, and of side effects in people prescribed compounded semaglutide or tirzepatide at doses beyond the approved label, more often, or with a faster climb4. Vials sold online as retatrutide are a different problem again, because that drug has no approved label to measure against at all. If you go the compounded route, I would ask for my dose in milligrams, the vial's concentration and the exact syringe marking in writing. I would not change it on my own.
Why the next step belongs to your prescriber
Tolerability, other medicines, blood sugar if you have diabetes and plans for pregnancy all shape the right dose. A moving-up reminder from an app is not the same as a prescriber deciding it is time. I would bring how I have felt for the past two weeks, any vomiting or trouble keeping fluids down, and my birth-control method to every dose conversation.
Severe stomach pain that will not ease, or vomiting that stops you holding down fluids, is a reason to call your prescriber the same day.
Frequently asked questions
What is the tirzepatide dosing schedule?
The Zepbound label starts at 2.5 mg once weekly for four weeks, then 5 mg. The dose may go up in 2.5 mg steps after at least four weeks on the current dose. Maintenance for weight is 5 mg, 10 mg or 15 mg weekly, and the maximum is 15 mg. Your prescriber decides whether and when to increase.
Is 2.5 mg of tirzepatide a maintenance dose?
No. The label says 2.5 mg is for starting treatment and is not approved as a maintenance dose. After four weeks, the label moves to 5 mg.
What if I miss a tirzepatide injection?
Under the Zepbound label, take the missed dose as soon as possible within four days (96 hours). If more than four days have passed, skip it and take the next dose on your usual day. If you have missed several weeks, ask your prescriber before restarting.
Do compounded tirzepatide programs use the same schedule?
Not necessarily. Compounded tirzepatide is not FDA approved and has no label of its own. Programs may use syringe units, flat pricing or smaller microdose plans. The FDA has reported dosing errors and side effects with compounded doses beyond the approved label, so get your dose in milligrams, the vial concentration and the syringe marking in writing.
References
- Eli Lilly and Company (2026). ZEPBOUND (tirzepatide) injection — Prescribing Information: sections 2.1 Recommended Dose Escalation, 2.2 Maintenance and Maximum Dosage, 2.3 Missed Dose and 8.3 Contraception. DailyMed / FDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
- Eli Lilly and Company (2026). LillyDirect: Zepbound KwikPen, single-dose vial and single-dose pen (dosage schedule and self-pay prices). Eli Lilly and Company. https://www.lilly.com/lillydirect/zepbound
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/35658024/
- U.S. Food and Drug Administration (2026). FDA's concerns with unapproved GLP-1 drugs used for weight loss (sections on dosing errors and doses beyond the approved label). FDA. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
One mom to another, not a doctor: everything here is for learning and figuring out your options, not medical advice, a diagnosis, or a plan for your body. Pregnancy planning and breastfeeding need advice for the exact medicine and formulation. Before you start, stop, or change anything, talk it through with a clinician who actually knows your history.
Continue reading
The Zepbound Savings Card and Vials: Who Actually Qualifies
Who qualifies for the Zepbound savings card, LillyDirect vial and KwikPen self-pay prices by dose as of November 2026, the 45-day refill rule and what it skips.
ReadRetatrutide: What I Want Moms to Know Right Now
Retatrutide trial results, why it is still not FDA-approved as of November 2026, and why the compounded or research-peptide versions sold online are not legitimate.
ReadCompounded Tirzepatide in 2026: What Changed and What I Would Ask
Where compounded tirzepatide stands as of November 2026: the FDA's shortage, 503A and 503B rules, safety questions to ask, and real price ranges.
ReadMicrodosing GLP-1s: The Honest Take on the Hype
What low-dose GLP-1 marketing means, what dose-response trials can support, and the questions to ask about monitoring, cost and compounded products.
ReadZepbound vs Mounjaro: Same Drug, Two Names, One Big Difference
Zepbound and Mounjaro are both tirzepatide. Why there are two names, and why which one you're prescribed changes what insurance does.
ReadHitting a GLP-1 Plateau: Evidence and Questions to Ask
A GLP-1 stall is normal — here's what the trial data say about why the scale flattens, the dose lever, non-scale wins, and when to call your prescriber.
Read